News
13h
MyChesCo on MSNArbutus Biopharma Showcases Promising Results for Hepatitis B Therapies at EASL Congress 2025Arbutus Biopharma Corporation (Nasdaq: ABUS) recently presented compelling data on its investigational hepatitis B therapies, ...
A highly contagious liver infection is surging among groups who are not typically at risk. At least seven people have died.
Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 ...
Health officials in Los Angeles County have declared a community-wide outbreak of hepatitis A following a sharp rise in cases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results